These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20079619)

  • 21. Caffeine consumption amongst British athletes following changes to the 2004 WADA prohibited list.
    Chester N; Wojek N
    Int J Sports Med; 2008 Jun; 29(6):524-8. PubMed ID: 18027309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport.
    Nelson AE; Ho KK
    Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An examination of the Sport Drug Control Model with elite Australian athletes.
    Gucciardi DF; Jalleh G; Donovan RJ
    J Sci Med Sport; 2011 Nov; 14(6):469-76. PubMed ID: 21514883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving athletes' perspectives of sport psychology consultation: a controlled evaluation of two interview methods.
    Donohue B; Dickens Y; Lancer K; Covassin T; Hash A; Miller A; Genet J
    Behav Modif; 2004 Mar; 28(2):182-93. PubMed ID: 14997947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NCAA institutionally based drug testing: do our athletes know the rules of this game?
    Albrecht RR; Anderson WA; McGrew CA; McKeag DB; Hough DO
    Med Sci Sports Exerc; 1992 Feb; 24(2):242-6. PubMed ID: 1549014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why young elite athletes fear failure: consequences of failure.
    Sagar SS; Lavallee D; Spray CM
    J Sports Sci; 2007 Sep; 25(11):1171-84. PubMed ID: 17654229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
    Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized response estimates for doping and illicit drug use in elite athletes.
    Striegel H; Ulrich R; Simon P
    Drug Alcohol Depend; 2010 Jan; 106(2-3):230-2. PubMed ID: 19740612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary supplementation of high-performance Canadian athletes by age and gender.
    Erdman KA; Fung TS; Doyle-Baker PK; Verhoef MJ; Reimer RA
    Clin J Sport Med; 2007 Nov; 17(6):458-64. PubMed ID: 17993788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A springtime olympics demands special consideration for allergic athletes.
    Katelaris CH; Carrozzi FM; Burke TV; Byth K
    J Allergy Clin Immunol; 2000 Aug; 106(2):260-6. PubMed ID: 10932068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes.
    Spence L; Brown WJ; Pyne DB; Nissen MD; Sloots TP; McCormack JG; Locke AS; Fricker PA
    Med Sci Sports Exerc; 2007 Apr; 39(4):577-86. PubMed ID: 17414793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are former female elite athletes more likely to experience urinary incontinence later in life than non-athletes?
    Bø K; Sundgot-Borgen J
    Scand J Med Sci Sports; 2010 Feb; 20(1):100-4. PubMed ID: 19000097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perceptions of elite coaches and sports scientists of the research needs for elite coaching practice.
    Williams SJ; Kendall L
    J Sports Sci; 2007 Dec; 25(14):1577-86. PubMed ID: 17852663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Participation in leanness sports but not training volume is associated with menstrual dysfunction: a national survey of 1276 elite athletes and controls.
    Torstveit MK; Sundgot-Borgen J
    Br J Sports Med; 2005 Mar; 39(3):141-7. PubMed ID: 15728691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of jumper's knee among elite athletes from different sports: a cross-sectional study.
    Lian OB; Engebretsen L; Bahr R
    Am J Sports Med; 2005 Apr; 33(4):561-7. PubMed ID: 15722279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health and doping in elite-level cycling.
    Lentillon-Kaestner V; Hagger MS; Hardcastle S
    Scand J Med Sci Sports; 2012 Oct; 22(5):596-606. PubMed ID: 21392123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of drug detection dogs in Sydney, Australia.
    Dunn M; Degenhardt L
    Drug Alcohol Rev; 2009 Nov; 28(6):658-62. PubMed ID: 19930020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Snuff use and smoking in Finnish olympic athletes.
    Alaranta A; Alaranta H; Patja K; Palmu P; Prättälä R; Martelin T; Helenius I
    Int J Sports Med; 2006 Jul; 27(7):581-6. PubMed ID: 16802255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.